Assessment of inhaled corticosteroid therapy for asthma treatment during pregnancy

Allergology International

Volumn 54, Issue 3, 2005, Pages 381-386

  Otsuka, Hidehiko ^a   Narushima, Michiaki ^a   Suzuki, Hajime ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Asthma; Fluticasone; Inhaled steroid; Perinatal abnormality; Pregnancy

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CESAREAN SECTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG SAFETY; DYSTOCIA; FEMALE; FETUS DEATH; FETUS DISTRESS; HUMAN; HYDRAMNIOS; INCIDENCE; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY TOXEMIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 25144466574     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.381     Document Type: Article

References (20)

1. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am. J. Respir. Crit. Care Med. 1988;158:1091-1095.
2. Wen SW, Demissie K, Liu S. Adverse outcomes in pregnancies of asthmatic women: Result from a Canadian population. Ann. Epidemiol. 2001;11:7-12.
3. Schatz M. Interrelationships between asthma and pregnancy: a literature review. J. Allergy Clin. Immunol. 1999; 103:8330-336.
4. Greenberger PA, Patterson R. The outcome of pregnancy complicated by severe asthma. Allergy Proc. 1988;9:539-543.
5. Schatz M, Zeiger RS, Hoffman CP et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am. J. Respir. Crit. Care Med. 1995;151:1170-1174.
6. National Institutes of Health, National Heart Lung and Blood Institute. National Asthma Education Program: Report of the working group on asthma and pregnancy. Management of asthma during pregnancy. NIH publication. Bethesda: National Institutes of Health, 1993.
7. Tan KS, Thomson NC. Asthma in pregnancy. Am. J. Med. 2000;109:727-733.
8. Schatz M. Asthma treatment during pregnancy. Drug Saf. 1997;16:342-350.
9. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch. Intern. Med. 1999;159:941-955.
10. Norjavaara E, de Verdier MG. Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide. J. Allergy Clin. Immunol. 2000;111:736-742.
11. Kallen B, Rydhstroem H, Aberg A. Congenital Malformations after the use of inhaled budesonide in early pregnancy. Obstet. Gynecol. 1999;93:392-395.
12. Dombrowski MP, Schatz M, Wise R et al. Asthma during pregnancy. Obstet. Gynecol. 2004;103:5-12.
13. Stenius AB, Riikonen S, Teramo K. Slow-release theophylline in pregnant asthmatics. Chest 1995;107:642-647.
14. Position statement. The use of newer asthma and allergy medications during pregnancy. Ann. Allergy Asthma Immunol. 2000;84:475-480.
15. Lebherz TB, Hellman LP, Madding R et al. Double-blind study of premature rupture of the membranes. Am. J. Obstet. Gynecol. 1963;87:218-225.
16. Gunn GC, Mishell DR, Morton DG. Premature rupture of the fetal membranes. Am. J. Obstet. Gynecol. 1970;106: 469-483.
17. Johnson JWC, Daikoku NH, Niebyl JR et al. Premature rupture of the membranes and prolonged latency. Obstet. Gynecol. 1981;57:547-556.
18. Trap R, Helm P, Lidegaad O et al. Premature rupture of the fetal membranes, the phases of the moon and barometer readings. Gynecol. Obstet. Invest. 1989;28:14-18.
19. Cooms CA, Kitzmiller JL. Preterm premature rupture of the membranes. In: Fuchs A, Fuchs FF, Stubblerfield PG (eds). Preterm Birth, 2nd edn. New York: McGraw-Hill, 1993.
20. Otsuka H, Yano R, Kagiyama N et al. [Education and control of bronchial asthma during pregnancy.] Jpn. J. Allergol. 2002;51:912 (in Japanese).